Intrinsic Value of S&P & Nasdaq Contact Us

The Now Corporation NWPN OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
11/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

The Now Corporation (NWPN) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.02. It has a SharesGrow Score of 10/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Net income is $3M (loss), growing at -15%/yr. Net profit margin is 0% (thin). Gross margin is 0% (+0 pp trend).

Balance sheet: total debt is $36M with negative equity of -$35M — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 0 (tight liquidity). Debt-to-assets is 2102.7%. Total assets: $2M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 0/100 (Fail), Moat 28/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

NWPN SharesGrow Score Overview

22/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 28/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Stock Chart & Stats

Market Data
52-Week Range0.0001-0.15
Volume447
Avg Volume (30D)65.83K
Market Cap$123.71M
Beta (1Y)-0.31
Share Statistics
EPS (TTM)0.00
Shares Outstanding$5.88B
IPO Date1999-04-06
Employees1
CEOAlfredo Nicholas Papadakis
Financial Highlights & Ratios
EBITDA$-41.6K
Net Income$-2.77M
Operating Income$-41.6K
Total Debt$36.01M
Net Debt$36.01M
Total Assets$1.71M
Price / Earnings (P/E)-36.8
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS67010T1034

Price Chart

NWPN
The Now Corporation  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.15
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message